Download PDF
Facial Plast Surg 2021; 37(06): 692-697
DOI: 10.1055/s-0041-1735638
Original Article

Bony Orbital Surgery for Graves' Ophthalmopathy

Adrian A. Ong 
1   Otolaryngology and Facial Plastic Surgery Associates, Fort Worth, Texas
,
Samuel DeVictor
2   Department of Otolaryngology, Jacobs School of Medicine and Biomedical Sciences, University at Buffalo, The State University of New York, Buffalo, New York
,
Aurora G. Vincent
1   Otolaryngology and Facial Plastic Surgery Associates, Fort Worth, Texas
,
Arya W. Namin 
1   Otolaryngology and Facial Plastic Surgery Associates, Fort Worth, Texas
,
Weitao Wang 
3   Department of Otolaryngology–Head and Neck Surgery, University of Rochester, Rochester, New York
,
Yadranko Ducic
1   Otolaryngology and Facial Plastic Surgery Associates, Fort Worth, Texas
› Author Affiliations
› Further Information
   Permissions and Reprints

Abstract

The majority of Graves' ophthalmopathy, or thyroid eye disease, can be managed medically; however, in refractory or severe cases, surgical intervention with orbital decompression may be necessary. The majority of the published literature is retrospective in nature, and there is no standardized approach to orbital decompression. The purpose of this review is to evaluate the various surgical approaches and techniques for orbital decompression. Outcomes are ultimately dependent on individual patient factors, surgical approach, and surgeon experience.

Keywords

orbital decompression - thyroid eye disease - Graves' ophthalmopathy

Note

The work herein does not necessarily represent the views of the United States government, Department of Defense or its affiliates.




Publication History

Article published online:
09 September 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Bartalena L, Tanda ML. Clinical practice. Graves' ophthalmopathy. N Engl J Med 2009; 360 (10) 994-1001
    CrossrefPubMedGoogle Scholar
  • 2 Thornton J, Kelly SP, Harrison RA, Edwards R. Cigarette smoking and thyroid eye disease: a systematic review. Eye (Lond) 2007; 21 (09) 1135-1145
    CrossrefPubMedGoogle Scholar
  • 3 Kim J, Choi MS, Park J. et al. Changes in thyroid stimulating hormone receptor antibody levels following total thyroidectomy or radioiodine therapy in patients with refractory Graves' disease. Thyroid 2021
    PubMedGoogle Scholar
  • 4 Ponto KA, Zang S, Kahaly GJ. The tale of radioiodine and Graves' orbitopathy. Thyroid 2010; 20 (07) 785-793
    CrossrefPubMedGoogle Scholar
  • 5 Bartalena L, Baldeschi L, Boboridis K. et al; European Group on Graves' Orbitopathy (EUGOGO). The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy. Eur Thyroid J 2016; 5 (01) 9-26
    CrossrefPubMedGoogle Scholar
  • 6 Bartalena L, Marcocci C, Tanda ML. et al. An update on medical management of Graves' ophthalmopathy. J Endocrinol Invest 2005; 28 (05) 469-478
    CrossrefPubMedGoogle Scholar
  • 7 Kazim M, Goldberg RA, Smith TJ. Insights into the pathogenesis of thyroid-associated orbitopathy: evolving rationale for therapy. Arch Ophthalmol 2002; 120 (03) 380-386
    CrossrefPubMedGoogle Scholar
  • 8 Smith TJ, Koumas L, Gagnon A. et al. Orbital fibroblast heterogeneity may determine the clinical presentation of thyroid-associated ophthalmopathy. J Clin Endocrinol Metab 2002; 87 (01) 385-392
    CrossrefPubMedGoogle Scholar
  • 9 Bartalena L, Pinchera A, Marcocci C. Management of Graves' ophthalmopathy: reality and perspectives. Endocr Rev 2000; 21 (02) 168-199
    PubMedGoogle Scholar
  • 10 Kacker A, Kazim M, Murphy M, Trokel S, Close LG. “Balanced” orbital decompression for severe Graves' orbitopathy: technique with treatment algorithm. Otolaryngol Head Neck Surg 2003; 128 (02) 228-235
    CrossrefPubMedGoogle Scholar
  • 11 Alsuhaibani AH, Carter KD, Policeni B, Nerad JA. Orbital volume and eye position changes after balanced orbital decompression. Ophthal Plast Reconstr Surg 2011; 27 (03) 158-163
    CrossrefPubMedGoogle Scholar
  • 12 Mainville NP, Jordan DR. Effect of orbital decompression on diplopia in thyroid-related orbitopathy. Ophthal Plast Reconstr Surg 2014; 30 (02) 137-140
    CrossrefPubMedGoogle Scholar
  • 13 Dubin MR, Tabaee A, Scruggs JT, Kazim M, Close LG. Image-guided endoscopic orbital decompression for Graves' orbitopathy. Ann Otol Rhinol Laryngol 2008; 117 (03) 177-185
    CrossrefPubMedGoogle Scholar
  • 14 Prevost A, Dekeister C, Caron P. et al. Outcomes of orbital decompression using surgical navigation in thyroid-associated ophthalmopathy. Int J Oral Maxillofac Surg 2020; 49 (10) 1279-1285
    CrossrefPubMedGoogle Scholar
  • 15 Antisdel JL, Gumber D, Holmes J, Sindwani R. Management of sinonasal complications after endoscopic orbital decompression for Graves' orbitopathy. Laryngoscope 2013; 123 (09) 2094-2098
    CrossrefPubMedGoogle Scholar
  • 16 De Riu G, Meloni SM, Gobbi R, Soma D, Baj A, Tullio A. Subciliary versus swinging eyelid approach to the orbital floor. J Craniomaxillofac Surg 2008; 36 (08) 439-442
    CrossrefPubMedGoogle Scholar
  • 17 Paridaens D, Lie A, Grootendorst RJ, van den Bosch WA. Efficacy and side effects of ‘swinging eyelid’ orbital decompression in Graves' orbitopathy: a proposal for standardized evaluation of diplopia. Eye (Lond) 2006; 20 (02) 154-162
    CrossrefPubMedGoogle Scholar
  • 18 Sasim IV, de Graaf ME, Berendschot TT, Kalmann R, van Isterdael C, Mourits MP. Coronal or swinging eyelid decompression for patients with disfiguring proptosis in Graves' orbitopathy? Comparison of results in one center. Ophthalmology 2005; 112 (07) 1310-1315
    CrossrefPubMedGoogle Scholar
  • 19 Walsh TE, Ogura JH. Transantral orbital decompression for malignant exophthalmos. Laryngoscope 1957; 67 (06) 544-568
    CrossrefPubMedGoogle Scholar
  • 20 Baldeschi L, MacAndie K, Hintschich C, Wakelkamp IM, Prummel MF, Wiersinga WM. The removal of the deep lateral wall in orbital decompression: its contribution to exophthalmos reduction and influence on consecutive diplopia. Am J Ophthalmol 2005; 140 (04) 642-647
    CrossrefPubMedGoogle Scholar
  • 21 Ben Simon GJ, Syed HM, Lee S. et al. Strabismus after deep lateral wall orbital decompression in thyroid-related orbitopathy patients using automated hess screen. Ophthalmology 2006; 113 (06) 1050-1055
    CrossrefPubMedGoogle Scholar
  • 22 Mehta P, Durrani OM. Outcome of deep lateral wall rim-sparing orbital decompression in thyroid-associated orbitopathy: a new technique and results of a case series. Orbit 2011; 30 (06) 265-268
    CrossrefPubMedGoogle Scholar
  • 23 Jefferis JM, Jones RK, Currie ZI, Tan JH, Salvi SM. Orbital decompression for thyroid eye disease: methods, outcomes, and complications. Eye (Lond) 2018; 32 (03) 626-636
    CrossrefPubMedGoogle Scholar
  • 24 Thapa S, Gupta AK, Gupta A, Gupta V, Dutta P, Virk RS. Proptosis reduction by clinical vs radiological modalities and medial vs inferomedial approaches: comparison following endoscopic transnasal orbital decompression in patients with dysthyroid orbitopathy. JAMA Otolaryngol Head Neck Surg 2015; 141 (04) 329-334
    CrossrefPubMedGoogle Scholar
  • 25 Yao WC, Sedaghat AR, Yadav P, Fay A, Metson R. Orbital decompression in the endoscopic age: the modified inferomedial orbital strut. Otolaryngol Head Neck Surg 2016; 154 (05) 963-969
    CrossrefPubMedGoogle Scholar
  • 26 DeParis SW, Tian J, Rajaii F. Practice patterns in orbital decompression surgery among American Society of Ophthalmic Plastic and Reconstructive Surgery members. Ophthalmol Ther 2019; 8 (04) 541-548
    CrossrefPubMedGoogle Scholar
  • 27 Wickwar S, McBain HB, Ezra DG, Hirani SP, Rose GE, Newman SP. Which factors are associated with quality of life in patients with Graves' orbitopathy presenting for orbital decompression surgery?. Eye (Lond) 2015; 29 (07) 951-957
    CrossrefPubMedGoogle Scholar
  • 28 Iacobæus L, Sahlin S. Evaluation of quality of life in patients with Graveś ophthalmopathy, before and after orbital decompression. Orbit 2016; 35 (03) 121-125
    CrossrefPubMedGoogle Scholar
  • 29 Mourits MP, Bijl H, Altea MA. et al; European Group on Graves' Orbitopathy (EUGOGO). Outcome of orbital decompression for disfiguring proptosis in patients with Graves' orbitopathy using various surgical procedures. Br J Ophthalmol 2009; 93 (11) 1518-1523
    CrossrefPubMedGoogle Scholar
  • 30 Leone Jr CR, Piest KL, Newman RJ. Medial and lateral wall decompression for thyroid ophthalmopathy. Am J Ophthalmol 1989; 108 (02) 160-166
    CrossrefPubMedGoogle Scholar
  • 31 Graham SM, Brown CL, Carter KD, Song A, Nerad JA. Medial and lateral orbital wall surgery for balanced decompression in thyroid eye disease. Laryngoscope 2003; 113 (07) 1206-1209
    CrossrefPubMedGoogle Scholar
  • 32 Shepard KG, Levin PS, Terris DJ. Balanced orbital decompression for Graves' ophthalmopathy. Laryngoscope 1998; 108 (11, Pt 1): 1648-1653
    CrossrefPubMedGoogle Scholar
  • 33 Unal M, Leri F, Konuk O, Hasanreisoğlu B. Balanced orbital decompression combined with fat removal in Graves ophthalmopathy: do we really need to remove the third wall?. Ophthal Plast Reconstr Surg 2003; 19 (02) 112-118
    CrossrefPubMedGoogle Scholar
  • 34 Goldberg RA, Perry JD, Hortaleza V, Tong JT. Strabismus after balanced medial plus lateral wall versus lateral wall only orbital decompression for dysthyroid orbitopathy. Ophthal Plast Reconstr Surg 2000; 16 (04) 271-277
    CrossrefPubMedGoogle Scholar
  • 35 Cansiz H, Yilmaz S, Karaman E. et al. Three-wall orbital decompression superiority to 2-wall orbital decompression in thyroid-associated ophthalmopathy. J Oral Maxillofac Surg 2006; 64 (05) 763-769
    CrossrefPubMedGoogle Scholar
  • 36 Korkmaz S, Konuk O. Surgical treatment of dysthyroid optic neuropathy: long-term visual outcomes with comparison of 2-wall versus 3-wall orbital decompression. Curr Eye Res 2016; 41 (02) 159-164
    CrossrefPubMedGoogle Scholar
  • 37 Russo V, Querques G, Primavera V, Delle Noci N. Incidence and treatment of diplopia after three-wall orbital decompression in Graves' ophthalmopathy. J Pediatr Ophthalmol Strabismus 2004; 41 (04) 219-225
    CrossrefPubMedGoogle Scholar
  • 38 Douglas RS, Kahaly GJ, Patel A. et al. Teprotumumab for the treatment of active thyroid eye disease. N Engl J Med 2020; 382 (04) 341-352
    CrossrefPubMedGoogle Scholar